BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Hemophilia Foundation of Southern California - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://hemosocal.org
X-WR-CALDESC:Events for Hemophilia Foundation of Southern California
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260225T190000
DTEND;TZID=America/Los_Angeles:20260225T201500
DTSTAMP:20260505T031006
CREATED:20260110T041856Z
LAST-MODIFIED:20260113T012514Z
UID:10000325-1772046000-1772050500@hemosocal.org
SUMMARY:HFSC Community Webinar
DESCRIPTION:WEBINAR INFORMATION \n“Discover a New Investigational Approach to VWD Treatment” \nStar Therapeutics’ is investigating a once-monthly subcutaneous prophylactic treatment for VWD called VGA039. \nIf you or someone in your family has any type of VWD\, please join us for an engaging session as Dr. Laura Guido\, Head of Medical Affairs at Star Therapeutics\, shares how VGA039 works\, its clinical development path\, and early trial results. Dr. Guido will also discuss our VIVID Clinical Trials and how to explore eligibility and participate. Bring your competitive spirit as you learn more through our interactive trivia! \nABOUT THE SPEAKER:  Laura Guido PharmD\, MBA\, BCPS\, Executive Director\, Medical Affairs at Star Therapeutics. Dr. Guido is a clinical pharmacist and leads Medical Affairs for VGA039 at Star Therapeutics. Previously\, she supported clinical development for hemophilia A gene therapy trials at BioMarin and spent numerous years in anticoagulation at Boehringer Ingelheim. Prior to joining industry\, Dr. Guido was a clinical pharmacist. \nTHANK YOU TO STAR THERAPEUTICS FOR YOUR SPONSORSHIP! \nNote: Session will be presented in English. Zoom link will be sent out prior to the meeting.
URL:https://hemosocal.org/event/hfsc-community-webinar/
CATEGORIES:HFSC Community Webinar
ATTACH;FMTTYPE=image/png:https://hemosocal.org/wp-content/uploads/2026/01/VWD-Webinar-2.25.26-Website-Graphic-v2.png
END:VEVENT
END:VCALENDAR